This review highlights the diverse cardiac etiologies of cardioembolic stroke and emphasizes the evolving role of direct oral anticoagulants in its prevention.
Supports DOAC preference in nonvalvular AF stroke prevention; leaves open optimal strategies across other cardioembolic sources.
Based on the data available in the literature and the results of their investigations, the authors give the present-day views of the role and place of cardiac diseases in the pathogenesis of cardioembolic stroke (CES). Among all causes of ischemic strokes, cardiogenic strokes are demonstrated to account for as high as 40%. Nonrheumatic atrial fibrillation, postinfarction changes, and rheumatic heart diseases are considered to be the leading causes of CES. Current recommendations for CES prevention are presented; the specific features of antithrombotic therapy are analyzed in detail.
No takes yet. Share an insight, caveat, or question.
Л.А. Гераскина (2013) conducted a review in Cardioembolic stroke. Antithrombotic therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: